200956-10-1

Basic information

• Product Name: 1-Piperidinecarboxylic acid, 3-hydroxy-3-(3-hydroxy-1-propynyl)-2-phenyl-, 1,1-dimethylethyl ester, (2S,3R)-
• CAS NO: 200956-10-1
• Molecular Formula: C19H25NO4
• Molecular Weight: 331.412
• Mol File: 200956-10-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1-Piperidinecarboxylic acid, 3-hydroxy-3-(3-hydroxy-1-propynyl)-2-phenyl-, 1,1-dimethylethyl ester, (2S,3R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 3-hydroxy-3-(3-hydroxy-1-propynyl)-2-phenyl-, 1,1-dimethylethyl ester, (2S,3R)-(200956-10-1)
• EPA Substance Registry System: 1-Piperidinecarboxylic acid, 3-hydroxy-3-(3-hydroxy-1-propynyl)-2-phenyl-, 1,1-dimethylethyl ester, (2S,3R)-(200956-10-1)

Safety Data

• Hazardous Substances Data: 200956-10-1(Hazardous Substances Data)

Upstream product

• 5272-36-6 3-trimethylsilyl-2-propyn-1-ol 
• 925-90-6 ethylmagnesium bromide 
• 191669-62-2 (S)-tert-butyl 3-carbonyl-2-phenylpiperidine-1-carboxylic acid 
• 148701-46-6 cis-(3S)-hydroxy-(2S)-phenylpiperidine 
• 159249-47-5 tert-butyl (2S,3S)-3-hydroxy-2-phenylpiperidine-1-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 200956-75-8 Z-(2S,3R)-1-tert-butoxycarbonyl-3-(3-hydroxyprop-1-en-1-yl)-2-phenylpiperidin-3-ol 
• 200954-98-9 (3R,5S,6S)-3-(2-benzyloxy-5-(trifluoromethoxy)phenyl)-6-phenyl-1-oxa-7-(tert-butoxycarbonyl)azaspiro[4.5]decane 
• 200956-77-0 (5R,6S)-6-phenyl-1-oxa-7-(tert-butoxycarbonyl)azaspiro[4.5]dec-3-ene 

Relevant articles and documents

Use of NK-1 receptor antagonists for treating major depressive disorders

The present invention provides methods for the treatment of major depressive disorders comprising oral administration of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist and pharmaceutical compositions comprising such a NK-1 receptor

Use of NK-1 receptor antagonists for treating stress disorders

The present invention provides the use of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of stress disorders without concomitant the